Introduced in House — H.R. 6130

119th CONGRESS

1st Session

H. R. 6130

IN THE HOUSE OF REPRESENTATIVES

November 19, 2025

Mr. Buchanan (for himself and Mr. Tonko) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend title XVIII of the Social Security Act to provide for Medicare coverage of blood-based dementia screening tests.

Section 1. Short title

This Act may be cited as the Alzheimer’s Screening and Prevention Act of 2025 or the ASAP Act.

Sec. 2. Medicare coverage of Alzheimer’s disease and related dementias early detection screening tests

(a) Coverage

Section 1861 of the Social Security Act (42 U.S.C. 1395x) is amended—

(1)

in subsection (s)(2)—

(A)

in subparagraph (JJ), by striking the semicolon at the end and inserting ; and; and

(B)

by adding at the end the following new subparagraph:

(KK)
Alzheimer’s disease and related dementias early detection screening tests (as defined in subsection (nnn));; and

(2)

by adding at the end the following new subsection:

(nnn) Alzheimer’s disease and related dementias early detection screening tests
The term Alzheimer’s disease and related dementias early detection screening test means a test furnished to an individual for the detection of the pre-symptomatic and early stage of Alzheimer’s disease or related dementias on or after January 1, 2028, that—
(1)
is cleared under section 510(k), classified under section 513(f)(2), or approved under section 515 of the Federal Food, Drug, and Cosmetic Act; and
(2)
is—
(A)
a genomic sequencing blood or blood product test; or
(B)
such other equivalent test, including a single-analyte test, blood test analysis of cell-free nucleic acids, multiplex panel test, whole genome sequencing, protein expression, whole exome, whole transcriptome, and medical imaging (which are based on blood, blood products, tissue, urine or other biospecimen), as the Secretary determines appropriate in providing results comparable to those obtained with a test described in subparagraph (A).

(b) Payment

Section 1833(h)(1)(A) of the Social Security Act (42 U.S.C. 1395l(h)(1)(A)) is amended by inserting Alzheimer’s disease and related dementias early detection screening tests under section 1861(nnn) and after including.